We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byWyatt Foley
Modified over 4 years ago
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Indications for Preservation, Resection and Reconstruction of the Facial Nerve in Parotid Cancer Guntinas-Lichius O Department of Otorhinolaryngology Institute of Phoniatry and Pedaudiology Friedrich-Schiller-University Jena Director: O. Guntinas-Lichius
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Background Paralysis of the face is caused in 5% of patients by a tumor invading the facial nerve. The most frequent extracranial cause is a malignant parotid tumor. The incidence of facial palsy by parotid cancer is 12-25%. Parotid cancer is a rare disease: 2% of head and neck cancer. Hence: Less than 0.5% of head neck cancer patients have parotid cancer with facial palsy. Hence: EBM studies are rare and difficult to perform.
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Preservation of the Facial Nerve in Parotid Cancer is possible, if … the patient with primary parotid cancer presents with normal facial nerve function (as >75% of patients do). an operation microscope is used. in cases of uncertainty: Electromyography shows no signs of nerve degeneration. there is no intraoperative microscopic suspicion of tumour infiltration of the nerve. EBM Level III
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Preservation of the Facial Nerve in Parotid Cancer … results often (~50%) in a transient facial paresis, but seldom (~3%) the patients develop a permanent paresis. in patients with normal facial function does not lead to inferior disease-free and overall survival than it would be after resection of the intact nerve. EBM Level II-3/III
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Resection of the Facial Nerve in Parotid Cancer is necessary if the nerve is infiltrated. Criteria: clinical palsy, electrical palsy, signs of infiltration, frozen section. Only the parts of the nerve are resected that are infiltrated. Because: Negative margins are very important for disease-free survival. And from the oncological point of view facial nerve infiltration is not different from any other tumor infiltration site. EBM Level II-1/II-3
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Reconstruction of the Facial Nerve in Parotid Cancer should be performed as fast as possible, i.e., at best in one-step procedure with cancer surgery gives best functional results (better than muscle/sling plasty). Primary repair is better than secondary reconstruction. Postoperative radiotherapy seems not to have a harmful effect on facial function. The defect often concerns the facial nerve fan. This could be repaired optimally by interposition grafts, hypoglossal- facial nerve jump anastomosis or a combined approach. EBM Level II-3/III
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 If only secondary reconstruction is possible … Because the patients fails the selections criteria for primary repair: extension of the nerve defect, localization, prognosis, age, general health status, wishes, status of the mimic muscles, it should be noted: The optimal time window for direct facial nerve suture or nerve grafting closes after 6 months. In such situation, up to 2 years after injury, a hypoglossal- facial nerve jump anastomosis should be considered. EBM Level II-3/III
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 If a nerve reconstruction is not possible … Masseter m. transposition is second choice. Is recommended in combination with nerve reconstruction. Static suspension is third choice. Autogenic and not alloplastic material is recommended: fascia lata and palmaris longus tendon. Free microvascular muscle transfer is typically not indicated in parotid cancer patients. Upper lid loading is a reliable method for eye reanimation. Temporalis muscle transposition is the best choice for reconstruction of the corner of the mouth because of its length and vector. EBM Level II-3/III
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008
Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Empfehlung D: Level 1: Es gibt ausreichende Nachweise für die Wirksamkeit aus systematischen Überblicksarbeiten (Meta-Analysen) über zahlreiche randomisiert-kontrollierte Studien. Level 2: Es gibt Nachweise für die Wirksamkeit aus zumindest einer randomisierten, kontrollierten Studie. Level 3: Es gibt Nachweise für die Wirksamkeit aus methodisch gut konzipierten Studien, ohne randomisierte Gruppenzuweisung. Level 4a: Es gibt Nachweis für die Wirksamkeit aus klinischen Berichten. Level 4b: Stellt die Meinung respektierter Experten dar, basierend auf klinischen Erfahrungswerten bzw. Berichten von Experten-Komitees. Recommendation USA Level I: Evidence obtained from at least one properly designed randomized controlled trial.randomized controlled trial Level II-1: Evidence obtained from well-designed controlled trials without randomization.randomization Level II-2: Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group.cohortcase-control Level II-3: Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled trials might also be regarded as this type of evidence. Level III: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees Anmerkungen - werden nicht im Vortrag gezeigt
Clival Chordoma Case in Pediatric Patient
In the name of GOD In the name of GOD.
Evidence-based Public Health Interventions Robert S. Lawrence, MD Bloomberg School of Public Health Johns Hopkins University April 20, 2005.
Recent advances in Radiotherapy of CNS Tumours Dr Vivek Bansal Director, Dept of Radiation Oncology HCG Cancer Centre,Sola Ahmedabad,Gujarat,India .
CANCER SCREENING 2011 DELAWARE CANCER EDUCATION ALLIANCE STEPHEN S. GRUBBS, M.D. HELEN F. GRAHAM CANCER CENTER DELAWARE CANCER CONSORTIUM OCTOBER 5, 2011.
Sample size estimation
516 (32723) Phase III trial comparing AC (x4)taxane (x4) with taxane (x8) as adjuvant therapy for node-positive breast cancer: Results of N-SAS-BC02.
Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Basal Cell Nevus Syndrome Daniel Berg M.D., FRCPC Director, Dermatologic Surgery University of Washington.
Borderline Resectable Pancreatic Carcinoma
Evaluation and management of Bell’s palsy Chunfu Dai Otolaryngology Department Fudan University.
A systematic review of interventions for children with cerebral palsy: state of the evidence Rohini R Rattihalli
HOW EVIDENCE AND EVIDENCE-BASED CLINICAL GUIDELINES HELP CAREGIVERS SUPPORT TREATMENT "Do Carers Care About Research? Laura (Collins) Lyster-Mensh, Executive.
Martina Rastovac Mentor: A. Žmegač Horvat. Actor Patrick Swayze died after a 20-month battle with pancreatic cancer. He was 57.Patrick Swayze.
NSABP PROTOCOL C-10: RESULTS A Phase II Trial of 5-Fluorouracil, Leucovorin and Oxaliplatin (mFOLFOX6) Plus Bevacizumab for Patients with Unresectable.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
METHODS OF CLOSURE FOR GASTROSCHISIS AND OMPHALOCELE
Chapter 7. Getting Closer: Grading the Literature and Evaluating the Strength of the Evidence.
© 2018 SlidePlayer.com Inc. All rights reserved.